Apoptotic abnormalities in differential gene expression in peripheral blood mononuclear cells from children with Fabry disease

Acta Paediatrica, International Journal of Paediatrics

Volumn 97, Issue SUPPL. 457, 2008, Pages 48-52

  Moore, David F ^a   Goldin, Ehud ^b   Gelderman, Monique P ^c   Robinson, Chevalia ^b   Baer, Jessica ^d   Ries, Markus ^b   Elkahloun, Abdel ^b   Brady, Roscoe O ^b   Schiffmann, Raphael ^b,e  

^a UNIVERSITY OF MANITOBA   (Canada)

^b NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^c CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

^d NATIONAL CANCER INSTITUTE   (United States)

^e NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Apoptosis inducing factor; Enzyme replacement therapy; Fabry disease; Neuronal apoptosis inhibitory protein; Peripheral blood mononuclear cells

Indexed keywords

AGALSIDASE ALFA; APOPTOSIS INDUCING FACTOR; NEURONAL APOPTOSIS INHIBITORY PROTEIN;

ADOLESCENT; APOPTOSIS; BLOOD SAMPLING; CELL ISOLATION; CHILD; CLINICAL ARTICLE; COMPARATIVE STUDY; CONFERENCE PAPER; CONTROLLED STUDY; DOWN REGULATION; EXPRESSED SEQUENCE TAG; FABRY DISEASE; FEMALE; GENE EXPRESSION; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC DIFFERENCE; HUMAN; HUMAN CELL; MALE; MICROARRAY ANALYSIS; MOLECULAR PROBE; NERVE CELL; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; RNA EXTRACTION; STATISTICAL SIGNIFICANCE; TREATMENT DURATION;

ALPHA-GALACTOSIDASE; CHILD; FABRY DISEASE; GENE EXPRESSION; HUMANS; ISOENZYMES; LEUKOCYTES, MONONUCLEAR; NEURONAL APOPTOSIS-INHIBITORY PROTEIN; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 41049089902     PISSN: 08035253     EISSN: 16512227     Source Type: Journal    
DOI: 10.1111/j.1651-2227.2008.00654.x     Document Type: Conference Paper

References (23)

1. Brady R, Gal A, Bradley R, Martensson E, Warshaw A, Laster L. Enzymatic defect in Fabry disease: ceramide trihexosidase deficiency. N Engl J Med 1967 276 : 1163 67.
2. Desnick RJ, Ioannou YA, Eng CM. α-galactosidase A deficiency: Fabry disease. In : Scriver CR, Beaudet AL, Sly WS, Valle D, editors. The metabolic and molecular bases of inherited disease. New York : McGraw-Hill, 2005 : 3733 74.
3. Mitsias P, Levine SR. Cerebrovascular complications of Fabry's disease. Ann Neurol 1996 40 : 8 17.
4. Altarescu G, Moore DF, Pursley R, Campia U, Goldstein S, Bryant M, et al. Enhanced endothelium-dependent vasodilation in Fabry disease. Stroke 2001 32 : 1559 62.
5. Moore DF, Altarescu G, Ling GS, Jeffries N, Frei KP, Weibel T, et al. Elevated cerebral blood flow velocities in Fabry disease with reversal after enzyme replacement. Stroke 2002 33 : 525 31.
6. Moore DF, Gelderman MP, Ferreira PA, Fuhrmann SR, Yi H, Elkahloun A, et al. Genomic abnormalities of the murine model of Fabry disease after disease-related perturbation, a systems biology approach. Proc Natl Acad Sci USA 2007 104 : 8065 70.
7. Moore DF, Scott LT, Gladwin MT, Altarescu G, Kaneski C, Suzuki K, et al. Regional cerebral hyperperfusion and nitric oxide pathway dysregulation in Fabry disease: reversal by enzyme replacement therapy. Circulation 2001 104 : 1506 12.
8. Moore DF, Ye F, Schiffmann R, Butman JA. Increased signal intensity in the pulvinar on T1-weighted images: a pathognomonic MR imaging sign of Fabry disease. Am J Neuroradiol 2003 24 : 1096 101.
9. Moore DF, Krokhin OV, Beavis RC, Ries M, Robinson C, Goldin E, et al. Proteomics of specific treatment-related alterations in Fabry disease: a strategy to identify biological abnormalities. Proc Natl Acad Sci USA 2007 104 : 2873 8.
10. Kaneski CR, Moore DF, Ries M, Zirzow GC, Schiffmann R. Myeloperoxidase predicts risk of vasculopathic events in hemizygous males with Fabry disease. Neurology 2006 67 : 2045 7.
11. DeGraba T, Azhar S, Dignat-George F, Brown E, Boutiere B, Altarescu G, et al. Profile of endothelial and leukocyte activation in Fabry patients. Ann Neurol 2000 47 : 229 33.
12. Irizarry R, Gautier L, Cope L. An R package for analysis of Affymetrix oligonucleotide arrays. In Parmigiani G, Garreyy ES, Irizarry R, Zeger SL, editors. The analysis of gene expression data. New York : Springer-Verlag, 2003 : 102 19.
13. Smyth G. Limma: Linear models for microarray data. In Gentleman R, Carey V, Huber W, Irizarry R, Dudoit S, editors. Bioinformatics and computational biology solutions using R and Bioconductor. New York : Springer-Verlag, 2005 : 397 420.
14. Overbergh L, Giulietti A, Valckx D, Decallonne R, Bouillon R, Mathieu C. The use of real-time reverse transcriptase PCR for the quantification of cytokine gene expression. J Biomol Tech 2003 14 : 33 43.
15. Hodge DR, Peng B, Cherry JC, Hurt EM, Fox SD, Kelley JA, et al. Interleukin 6 supports the maintenance of p53 tumor suppressor gene promoter methylation. Cancer Res 2005 65 : 4673 82.
16. Modjtahedi N, Giordanetto F, Madeo F, Kroemer G. Apoptosis-inducing factor: vital and lethal. Trends Cell Biol 2006 16 : 264 72.
17. Moore DF, Li H, Jeffries N, Wright V, Cooper RA Jr., Elkahloun A, et al. Using peripheral blood mononuclear cells to determine a gene expression profile of acute ischemic stroke: a pilot investigation. Circulation 2005 111 : 212 21.
18. Moore DF, Ye F, Brennan ML, Gupta S, Barshop BA, Steiner RD, et al. Ascorbate decreases Fabry cerebral hyperperfusion suggesting a reactive oxygen species abnormality: an arterial spin tagging study. J Magn Reson Imaging 2004 20 : 674 83.
19. Roy N, Mahadevan M, McLean M, Shutler G, Yaraghi Z, Farahani R, et al. The gene for neuronal apoptosis inhibitory protein is partially deleted in individuals with spinal muscular atrophy. Cell 1995 13 : 167 78.
20. Okada Y, Sakai H, Kohiki E, Suga E, Yanagisawa Y, Tanaka K, et al. A dopamine D4 receptor antagonist attenuates ischemia-induced neuronal cell damage via upregulation of neuronal apoptosis inhibitory protein. J Cereb Blood Flow Metab 2005 25 : 794 806.
21. Wesche-Soldato DE, Swan RZ, Chung CS, Ayala A. The apoptotic pathway as a therapeutic target in sepsis. Curr Drug Targets 2007 8 : 493 500.
22. Tschopp J, Martinon F, Burns K. NALPs: a novel protein family involved in inflammation. Nat Rev Mol Cell Biol 2003 4 : 95 104.
23. Martinon F, Tschopp J. Inflammatory caspases and inflammasomes: master switches of inflammation. Cell Death Differ 2007 14 : 10 22.